According to a recently-filed 13D, notorious investor Seth Klarman‘s Baupost Group currently owns a substantial position in the OTC stock Biotie Therapies Corp (OTCMKTS:BIOZF). The filing showed that Baupost owns 172.71 million shares of Biotie Therapies Corp, the activist position amassing over 17% of the company’s outstanding stock.
You can access the original SEC filing by clicking here.
Ownership Summary Table
|Name||Sole Voting Power||Shared Voting Power||Sole Dispositive Power||Shared Dispositive Power||Aggregate Amount Owned Power||Percent of Class|
|The Baupost Group, L.L.C.04-3402144||0||172,711,112||0||172,711,112||172,711,112||17.1%|
|Seth A. Klarman||0||172,711,112||0||172,711,112||172,711,112||17.1%|
Page 1 of 6 SEC Filing
AND EXCHANGE COMMISSION
the Securities Exchange Act of 1934
Class of Securities)
The Baupost Group, L.L.C.
10 St. James Avenue, Suite 1700,
Phone : (617) 210-8300
Address and Telephone Number of Person Authorized to Receive Notices and
Event which Requires Filing of this Statement)
filing person has previously filed a statement on Schedule 13G to report the
acquisition that is the subject of this Schedule 13D, and is filing this
schedule because of §§240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the
format shall include a signed original and five copies of the schedule,
including all exhibits. See §240.13d-7 for other parties to whom copies are to
remainder of this cover page shall be filled out for a reporting person’s
initial filing on this form with respect to the subject class of securities, and
for any subsequent amendment containing information which would alter
disclosures provided in a prior cover page.
information required on the remainder of this cover page shall not be deemed to
be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934
(“Act”) or otherwise subject to the liabilities of that section of the Act but
shall be subject to all other provisions of the Act (however, see the